COSENTINO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 26.658
EU - Europa 16.465
AS - Asia 10.542
SA - Sud America 1.274
AF - Africa 235
Continente sconosciuto - Info sul continente non disponibili 37
OC - Oceania 28
Totale 55.239
Nazione #
US - Stati Uniti d'America 26.332
IT - Italia 7.544
SG - Singapore 3.388
UA - Ucraina 2.702
CN - Cina 2.340
SE - Svezia 1.576
TR - Turchia 1.522
VN - Vietnam 1.464
HK - Hong Kong 1.109
BR - Brasile 1.105
DE - Germania 895
FI - Finlandia 793
IE - Irlanda 734
GB - Regno Unito 681
FR - Francia 628
RU - Federazione Russa 382
IN - India 215
MX - Messico 161
CA - Canada 133
JP - Giappone 117
BD - Bangladesh 89
PL - Polonia 75
AR - Argentina 72
NG - Nigeria 67
NL - Olanda 67
ZA - Sudafrica 65
BE - Belgio 58
CZ - Repubblica Ceca 58
ES - Italia 58
CH - Svizzera 49
IQ - Iraq 48
EU - Europa 31
AT - Austria 30
LT - Lituania 27
PK - Pakistan 27
UZ - Uzbekistan 26
EC - Ecuador 25
MA - Marocco 22
ID - Indonesia 21
AE - Emirati Arabi Uniti 19
AU - Australia 19
KE - Kenya 18
CO - Colombia 17
DZ - Algeria 17
JO - Giordania 17
PH - Filippine 16
CL - Cile 15
IL - Israele 15
MY - Malesia 14
PY - Paraguay 14
RO - Romania 14
SA - Arabia Saudita 14
EG - Egitto 12
NP - Nepal 11
BG - Bulgaria 10
HU - Ungheria 10
TN - Tunisia 10
VE - Venezuela 9
GR - Grecia 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
SM - San Marino 8
AZ - Azerbaigian 7
KR - Corea 7
RS - Serbia 7
DK - Danimarca 6
LB - Libano 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
CR - Costa Rica 5
ET - Etiopia 5
HN - Honduras 5
JM - Giamaica 5
KZ - Kazakistan 5
NO - Norvegia 5
OM - Oman 5
TH - Thailandia 5
UY - Uruguay 5
GY - Guiana 4
KG - Kirghizistan 4
MD - Moldavia 4
PA - Panama 4
AF - Afghanistan, Repubblica islamica di 3
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
GA - Gabon 3
GD - Grenada 3
HR - Croazia 3
KW - Kuwait 3
LU - Lussemburgo 3
PE - Perù 3
SR - Suriname 3
TL - Timor Orientale 3
TW - Taiwan 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
Totale 55.193
Città #
Milan 4.925
Fairfield 2.129
Chandler 2.105
Jacksonville 2.081
San Jose 1.974
Singapore 1.957
Ashburn 1.919
Woodbridge 1.696
Dallas 1.564
Hong Kong 1.097
Ann Arbor 1.077
Houston 1.035
Wilmington 921
Seattle 892
Cambridge 749
Izmir 725
Dublin 724
Princeton 718
Dearborn 654
Nyköping 610
Beijing 585
The Dalles 493
Dong Ket 445
Boardman 408
Rome 395
Chicago 377
Como 361
Lauterbourg 347
San Mateo 286
New York 262
Los Angeles 253
Ho Chi Minh City 219
Helsinki 191
Hanoi 172
San Diego 168
Santa Clara 155
London 143
Orem 141
Munich 137
Ogden 137
Tokyo 117
Mexico City 109
Council Bluffs 108
São Paulo 107
Guangzhou 91
Frankfurt am Main 87
Hefei 84
Washington 82
Chennai 81
Des Moines 72
Warsaw 68
Düsseldorf 67
Abuja 65
Denver 62
Nanjing 59
Montreal 55
Phoenix 55
Kunming 53
Atlanta 51
Norwalk 51
Verona 51
Brno 50
Shanghai 50
Buffalo 49
Brussels 48
Johannesburg 47
Redwood City 47
Varese 47
Stockholm 46
Poplar 43
Hangzhou 42
Manchester 42
Amsterdam 39
Brooklyn 39
Ponte Lambro 39
Zhengzhou 39
Berlin 36
Rio de Janeiro 35
Tianjin 35
Da Nang 33
Jinan 33
Mountain View 33
San Francisco 33
Columbus 32
Toronto 30
Brasília 29
Pune 28
Shenyang 27
Ankara 26
Boston 26
Mumbai 25
Auburn Hills 23
Belo Horizonte 23
Haiphong 23
Biên Hòa 21
Fuzhou 20
Paris 20
Tashkent 20
New Delhi 19
Shenzhen 19
Totale 38.118
Nome #
1-year statin treatment reverts the pro-inflammatory cytokine interleukin-8 release of primed neutrophils in dyslipidemic subjects 1.163
Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals 443
Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia 269
Adrenergic modulation of migration, CD11b and CD18 expression, ROS and interleukin-8 production by human polymorphonuclear leukocytes 257
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 256
Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2 245
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment 244
Adrenergic regulation of innate immunity: a review 244
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias 237
Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease 233
Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. 232
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 232
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 227
Adrenergic modulation of immune cells: an update 226
Isoflavone content and estrogenic activity of different batches of red clover (Trifolium pratense L.) extracts: An in vitro study in MCF-7 cells 226
An unusual systemic reaction associated with topical salicylic acid in a paediatric patient 223
Acetylcholine detection by a modified HPLC-ED method improves the assessment of cholinergic function in the myenteric plexus of the guinea-pig colon. 223
Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. 222
Peripheral CD4+CD25+ Regulatory T-cell Frequency is Increased in High-Cardiovascular-Risk Subjects and is not Modified after 1-month Statin Treatment: a Longitudinal Study. 219
Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease 219
Production of IL-8, VEGF and elastase by circulating and intraplaque neutrophils in patients with carotid atherosclerosis 218
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines. 217
Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease 217
7-hydroxymatairesinol potassium acetate (Hmr/LignanTM) from Norway spruce (Picea abies) knots and its active metabolite enterolactone exert estrogenic effects in the in MCF-7 cell model. 216
Muscarinic modulation of endogenous noradrenaline release from adrenergic terminals in the guinea-pig colon. 216
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients 214
Association between the circadian course of endogenous noradrenaline and the hematopoietic cell cycle in mouse bone marrow. 211
Characterization of human leukocyte-HUVEC adhesion: Effect of cell preparation methods 211
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines 210
The essential oil of bergamot stimulates reactive oxygen species production in human polymorphonuclear leukocytes 210
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study 208
Dopaminergic D-1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes 208
Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients 207
Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection? 206
Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignantrade mark) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells. 204
Scanning electron microscopy examination of endothelium morphology in human carotid plaques 202
Dopaminergic inhibition of human neutrophils is exerted through D1-like receptors and affected by bacterial infection 200
Are CYP1A2*1F and *1C associated with clozapine tolerability? A preliminary investigation. 200
Improved solubility and increased biological activity of NeoSol (TM) RCL40, a novel Red Clover Isoflavone Aglycones extract preparation 198
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 197
Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis 197
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 196
cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms 196
Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors 195
Clopidogrel pharmacogenetics: Associations between genotype and stent thrombosis risk in patients with stent placement 195
Production of proinflammatory mediators by human neutrophils during long-term culture 194
Effects of a commercial product containing guaraná on psychological well-being, anxiety and mood: a single-blind, placebo-controlled study in healthy subjects 192
Levodopa-induced neutropenia 192
Gene expression of adhesion molecules in endothelial cells from patients with peripheral arterial disease is reduced after surgical revascularization and pharmacological treatment 191
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 191
Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence 190
Modulation of enteric cholinergic neurons by hetero- and autoreceptors: cooperation among inhibitory inputs 189
Calcium channel blockers and gastrointestinal motility: basic and clinical aspects 189
Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells 189
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 189
Endogenous catecholamine synthesis, metabolism storage, and uptake in human peripheral blood mononuclear cells 187
Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy. 186
Immunomodulatory properties of Achyrocline satureioides (Lam.) D.C. infusion: a study on human leukocytes. 186
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: Evidence for a D1-like receptor-dependent protective effect 186
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy 186
Two patients with COMT inhibitor–induced hepatic dysfunction and UGT1A9 genetic polymorphism 185
Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients 185
Immunomodulatory activity of the lignan 7-hydroxymatairesinol potassium acetate (HMR/LignanTM) extracted from the heartwood of norway spruce (Picea abies) 184
Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytes. 184
Levels of mRNA for dopaminergic receptor D₅ in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis 184
Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors. 183
Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function 183
Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils 183
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 179
Dopamine, T cells and multiple sclerosis (MS) 179
Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? 178
Assessment of catecholamine content and metabolism in human pheripheral blood leukocytes subpopulation and leukemia cell lines 177
Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study 177
HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines 177
Increased expression of dopamine receptors in synovial fibroblasts from patients with rheumatoid arthritis: inhibitory effects of dopamine on interleukin-8 and interleukin-6 177
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) 177
Adverse drug events in emergency department population: a prospective Italian study. 174
Lack of relationship between cardiovascular reactivity to mental stress and autonomic modulation of the sinoatrial node in normotensive and hypertensive male subjects 174
A rapid and sensitive method to assay endogenous acetylcholine overflow from myenteric neurons by means of HPLC and electrochemical detection. 174
Key learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study. 174
Laminar pattern of mineral calcium-phosphorus deposits in a human carotid plaque: nanoscale ultrastructure and elemental analysis 173
“Patterns” di deposito di calico-fosforo nelle placche carotidee nell’uomo. 172
Angiotensin II Type1 and type2 receptor expression in circulating monocytes of diabetic patients over 3-month rosuvastatin treatment 172
Simvastatin treatment in subjects at high cardiovascular risk modulates AT(1)R expression on circulating monocytes and T lymphocytes 171
Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy. 171
Atorvastatin treatment influences polymorphonuclear leukocyte function: a longitudinal study. 171
Diazepam stimulates migration and phagocytosis of human neutrophils: Possible contribution of peripheral-type benzodiazepine receptors and intracellular calcium 170
Effects of atorvastatin treatment on the modulation of leukocyte function in patients undergoing peripheral vascular intervention: a longitudinal study 170
Treatment with simvastatin modifies AT1R expression and function in polymorphonuclear leukocyte of high cardiovascular risk subjects: a longitudinal study 170
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment 170
Effects of carbamazepine on human PMN function: possible role of peripheral benzodiazepine receptors. 169
Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies 169
Studi sul ruolo di diversi sistemi recettoriali nella modulazione della liberazione di neurotrasmettitori dal plesso mienterico. 168
Adverse reaction to COMT inhibitors in Parkinson's disease patients: possible association with the UGTIA9 gene haplotype 168
Functional interaction between presynaptic receptors modulating transmitter release in the Autonomic Nervous System. 167
Produzione di Tumor Necrosis Factor-a; e Interleuchina-4 dai linfociti circolanti e di Interleuchina-8 dai neutrofili in pazienti con sindrome delle apnee notturne: variazioni durante terapia notturna con pressione continua positiva nelle vie aeree. 167
Multiple sclerosis: Repurposing dopaminergic drugs for MS - The evidence mounts 167
Dietary supplement and drug use and doping knowledge and attitudes in italian young elite cyclists 166
CD4+CD25+ regulatory T cell population in atherosclerosis: pharmacological modulation. 165
β 2 -Adrenoceptors inhibit neutrophil extracellular traps in human polymorphonuclear leukocytes 165
Totale 20.795
Categoria #
all - tutte 208.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.581 0 0 0 0 0 0 0 0 0 243 490 848
2021/20224.066 377 456 383 578 198 186 152 203 194 514 314 511
2022/20235.478 499 372 456 636 353 1.164 29 741 732 175 209 112
2023/20247.971 1.238 1.189 1.278 1.519 1.497 586 42 170 216 66 49 121
2024/20255.474 64 103 1.054 156 157 279 284 446 524 455 508 1.444
2025/202613.575 1.097 1.033 1.248 1.890 1.450 881 2.925 925 1.436 690 0 0
Totale 55.512